Cytyc Corporation Management Team to Present at Thomas Weisel Partners Healthcare Tailwinds Conference.Business Editors BOXBOROUGH, Mass.--(BUSINESS WIRE)--Aug. 28, 2003 Cytyc Corporation (Nasdaq: CYTC) today announced that Patrick J. Sullivan, chairman, president, and chief executive officer, is scheduled to present at the Thomas Weisel Partners Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG), often shortened to just TWP or TWeisel, is a U.S. middle-market and growth focused investment banking firm based in San Francisco, California. Healthcare Tailwinds Conference on September 3, 2003, at 8:00 a.m. (Eastern time) in Boston at the Four Seasons Hotel. Daniel J. Levangie, president and chief executive officer of Cytyc Health Corporation, and Robert L. Bowen, Cytyc's chief financial officer, will participate with Mr. Sullivan in the presentation, which will be an interactive discussion with conference attendees. A live webcast and recording of the presentation will be available on Cytyc's website, http://ir.cytyc.com. The recording will be available approximately three hours after the presentation until September Until September is a 1984 romantic drama set in France. It stars Karen Allen as an American tourist in Paris who falls in love with a married Frenchman (Thierry Lhermitte). External links 12, 2003. Cytyc Corporation designs, develops, manufactures, and markets the ThinPrep ThinPrep™ Cytology A proprietary system–Cytec, Inc, in which specimens are obtained with a special fluid collection system and the slides for cytologic examination are spread in one-cell-thick layers. See thin prep. (R) System for use in medical diagnostic applications primarily focused on women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. . The ThinPrep System is widely used for cervical cancer Cervical Cancer Definition Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably, forming tumors. screening and is the platform from which the Company has launched its expansion into breast cancer risk assessment with the FirstCyte (TM)Breast Test. The ThinPrep System consists of the ThinPrep(R) 2000 Processor, ThinPrep(R) 3000 Processor, ThinPrep(R) Imaging System, and related reagents, filters, and other supplies. Cytyc is traded on The Nasdaq Stock Market Nasdaq stock market The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies. under the symbol CYTC. Cytyc and ThinPrep are registered trademarks of Cytyc Corporation. FirstCyte is a trademark of Cytyc Corporation for which registration has been applied. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion